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Abstract: Systemic capillary leak syndrome (SCLS) is a rare disorder
with episodes of hypotension, hypoalbuminemia, and hemoconcentra-
tion. During attacks endothelial hyperpermeability results in leakage of
plasma proteins into the interstitial space. Attacks vary in severity and
may be lethal.
A 49-year-old previously healthy man was admitted to hospital for
hypovolemic shock, anasarca with pleuropericardial effusion, muscle
fatigue, and oliguria occurring after a flu-like syndrome. Laboratory
data showed an increase in hematocrit (65%), leucocytes (24.590m/L),
creatinine (2.5mg/dL), creatine phosphokinase (10.000U/L), and a
decrease in serum albumin (17 g/L) without proteinuria. Immunoglo-
bulins of class G/l monoclonal gammopathy were detected (1.3 g/L).
The initial suspicions addressed to a protein-loosing syndrome or to an
effort-related rhabdomyolysis. Initial therapy was based on steroids,
albumin, and high molecular weight plasma expanders (hydroxyethyl
starch). Because of high hematocrit, phlebotomy was also performed.
The patient had complete clinical remission and a diagnosis of SCLS
was finally made. He received prophylactic therapy with verapamil and
theophylline that was self-stopped for intolerance (hypotension and
tachycardia). He had a new crisis 2 days after a physical effort, and was
admitted in intensive care unit. The patient died for severe hypovolemic
shock with multiorgan failure and sudden cardiac arrest 15 hours after
hospital admission. Postmortem investigation revealed massive inter-
stitial edema of main organs with myocardial hyperacute ischemia.
Studies on SCLS are limited for the rarity of the disease and its
unpredictable course. Both prophylactic and acute crisis treatments are
empirical and optimal management of severe attacks is still lacking.
(Medicine 94(9):e591)
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S ystemic capillary leak syndrome (SCLS), also known asClarkson disease, is a rare disorder characterized by epi-
sodes of severe hypotension, hypoalbuminemia, and hemocon-
centration.1 A monoclonal gammopathy of unknown
significance, typically of the immunoglobulins of class G
(IgG) class, is present in most of the SCLS adult cases.2,3
During acute crisis of SCLS, profound derangement of the
vascular endothelium results in leakage of plasma and proteins
into the interstitial compartment. Episodes differ in severity and
frequency and may be life-threatening. SCLS was first
described about 50 years ago, and is variably referred to as
Clarkson disease or syndrome.1 Approximately 250 cases of
SCLS have been reported worldwide since 1960.3–5 The 5-year
survival rate is about 75%, and deaths are most commonly
related to acute SCLS events. These have been diagnosed
primarily in middle-aged adults, although cases in children
have also been reported.5,6 We describe here a case of fatal
SCLS associated with physical effort.
CASE PRESENTATION
A 49-year-old Italian man was admitted to hospital in
August 2012 for suspected gastroenteritis. He was a pharma-
ceutical representative practicing sports during free time. The
patient had a previous diagnosis of microurolithiasis with
calcific prostatitis, and his relevant clinical history had began
in April 2012, 2 days after a marathon (a long-distance running
with of 42 km) with a flu-like syndrome characterized by fever
(37.58C), muscle weakness, and dyspnoea. On that occasion, he
went to the emergency department (ED) where his blood tests
revealed high hemoglobin levels (18.9 g/dL, hematocrit 54%),
with mild increase in serum creatinine (1.3mg/dL). Symptoms
and blood test were ascribed to dehydratation secondary to the
prolonged physical effort. Assumption of eritropoietin as ana-
bolic substance and/or diuretics was also suspected but firmly
denied by the patient. He therefore underwent hydratation and
phlebotomy. He was discharged and then addressed to hem-
atological investigation. Primary or secondary polycythemia
was excluded by the absence of mutation in Janus kinase 2 gene
and normal arterial gas analysis. Clinically, the patient rapidly
improved but inMay 2012 he developed progressive swelling of
the face and of the lower limbs within 12 hours, after apparently
no preceding efforts, with body weight increase of about 10 kg.
Oral furosemide (50mg) and steroid (prednisone 25mg)
assumption given by his general practitioner for a few days
was followed by prompt reduction of edema and body weight.2, he had a running of 18 km. Three days
gastrointestinal symptoms with nausea,
pain, diarrhea, and fever (38.58C). He
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therefore took oral paracetamol 500mg thrice a day and meto-
clopramide for 2 days with no appreciable improvement. He
went to the ED for the occurrence of deep asthenia, hypoten-
sion, and oligoanuria. Blood test showed hemoglobin levels of
22 g/dL, hematocrit 64%, and creatinine 2.7mg/dL (Table 1).
The patient was therefore admitted to the Internal Medicine
ward. He presented with bilateral edema of the legs and fore-
arms. The blood pressure was 90/50mm Hg, the electrocardio-
gram (ECG) showed sinus tachycardia. Echocardiography and
thoracoabdominal computed tomography were negligible.
Hypotension was treated with saline solutions and dopamine
infusion (4mcg/kg/min). However, because of persistent hypo-
tension and occurrence of increasing anasarcatic state with
lower limb weakness, he was transferred to intensive care unit
where he was treated with albumin infusion and phlebotomy
(total amount of 600mL). ECG showed paroxysmal atrial flutter
with ST-depression on V1–3 derivations. Because he also
developed numbness, tingling, and weakness of both his legs,
Guillain–Barre` syndrome was suspected. Cerebral nuclear
magnetic resonance, electromyogram, and rachicenthesis at
that time were unremarkable. Heart ultrasound investigation
showed no abnormalities with a normal ejection fraction (57%).
The patient progressively improved and was then trans-
ferred to our Internal Medicine Unit. During hospital admission,
his clinical state remained stable with the exception of a mild
residual perimalleolar edema, which recovered quickly after the
use of mild doses of furosemide. However, he continued to
complain of symmetrical paresthesia of the calves (with sock-
like distribution), and this time an electromyogram revealed
axonal sensitive polyneuropathy of lower limbs. The cause of
the observed hypoalbuminemia was investigated. He was well
nourished and did not have any evidence of chronic inflam-
matory conditions, and the measured proteinuria of 0.63 g/24 h
was unlikely to explain the degree of observed perimalleolar
swelling. Serum tryptase and C1 esterase levels were normal.
The patient was then discharged and the typical clinical pres-
entation was recognized as SCLS. This diagnosis was con-
firmed after a second evaluation at another hospital center. At
discharge a prophylactic therapy with verapamil 40mg twice a
day (up to 240mg) and theophylline 375mg every day were
prescribed. However, this treatment was discontinued by the
patient’s own decision, because of reported intolerance for
hypotension, heart palpitations, and tremor.
On December 2012, the patient complained of fever,
tiredness, diarrhea, oliguria, facial and lower limb swelling,
cough, and x-ray detection of right pneumonia. Blood pressure
was normal. Fever and symptoms improved after a course of
therapy with levofloxacin, use of plasma expanders (6% hydro-
xyethyl starch), and low doses of diuretics. The symptom
improved within a few days.
On January 2013, after 2 days of a sustained physical
exertion (ski mountaineering), the patient complained again of
progressive drowsiness, oliguria, swelling of the limbs, and
hypotension but no fever, cough, or diarrhea. He was therefore
admitted to intensive care unit and unsuccessfully treated with
plasma expanders, steroids, and dopamine infusion. Fifteen
hours later he died with a multiorgan dysfunction syndrome
and sudden cardiac arrest despite resuscitative efforts.
At necropsy, the pathological findings were characterized
by moderate bilateral pleural and pericardial effusion and by a
diffuse interstitial edema involving lungs, liver and kidney, and
Zancanaro et alsoft tissues. The most important finding was a prominent
myocardial edema associated with contraction bands and hydro-
pic swelling of myocardial fibers and early extravasation of
2 | www.md-journal.compolymorphonucleocytes producing the morphological pattern of
acute myocardial infarction in its very early phase. Main
coronary arteries and intramyocardial vessels were normal
(Figure 1A and B).
DISCUSSION
Idiopathic SCLS is a rare disorder characterized by inter-
mittent attacks of diffuse microvascular hyperpermeability.
During acute episodes, the seepage of fluids and proteins from
the intravascular space results in diffuse or segmental edema,
hemoconcentration, and hypotension.1,3 Attacks greatly vary in
severity and may be lethal, but the final cause of death still
remains unclear. We here reported a fatal case of SCLS due to
sudden cardiac arrest in whom, to the best of our knowledge,
postmortem examination was performed for the first time and
myocardial histology has been described.
The original description of Clarkson in 1960 in New York
Hospital reported an otherwise healthy 34-year-old white
woman of Italian descent who on repeated occasions had
massive swelling of the face, arms, and legs, with progressively
decreasing, and finally unmeasurable blood pressure with irre-
versible hypovolemic shock.1 Since then,<300 cases have been
reported worldwide.7
The pathophysiology of SCLS remains poorly defined.
Several studies have found that the majority of patients in series
and case reports had monoclonal proteins.3,8,9 Monoclonal IgG
gammopathy was observed in 25 of a case series of 28 patients
(89%) from a European registry.3 The paraproteins are most
often of the IgG class with k light chains typically identified in
the serum.10,11 Paraprotein is probably not directly involved for
disrupting the vascular endothelial barrier, because studies in
which healthy endothelial cells were exposed in vitro to para-
proteins of patients showed no effects.12 Moreover, the amount
of monoclonal immunoglobulin produced is small and not
fluctuating, whereas symptoms usually are. Xie et al12 recently
showed that circulating permeability factors in SCLS serum
induce endothelial permeability in vitro by disrupting endo-
thelial adherens junctions and cause cell retraction without
inducing cell death. This reaction occurred even when the
immunoglobulins’ fraction of the serum were removed and
prevented in the presence of intravenous immunoglobulin
(IVIG). They propose that vascular endothelial growth factor
and angiopoietin 2 may be the factors involved, as both were
found to be elevated in episodic SCLS sera but not in remission
sera.12
In our patient, the association between progressive edema,
severe hypotension with multiple organ dysfunction, inspissatio
sanguinis with elevated hematocrit, decreased albumin
levels, rhabdomyolysis, and monoclonal gammopathy finally
addressed to the diagnosis. The main trigger for acute episode
was physical exercise, although a concomitant gastroenteric
infection might not be excluded on one occasion. In a series of
28 patients with SCLS, Gousseff et al3 found that the potential
triggers for attacks were infections (74%), mainly of the upper
respiratory tract, and sustained physical effort in a minority of
patients (7%).
A protein-loosing syndrome (enteric and/or renal) was first
suspected in our patient, but this hypothesis was not confirmed
afterwards. The slight proteinuria first detected improved
spontaneously, being a frequent finding in physical efforts.
Moreover, rhabdomyolysis was first wrongly ascribed to the
Medicine  Volume 94, Number 9, March 2015strenuous exercise and/or to paracetamol therapy,13 but after a
more detailed clinical history in our patient creatine phospho-
kinase and myoglobin elevation were found to occur after the
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Laboratory Studies During Hospital Admissions (Abnormal Results in Bold)
Test (Reference Ranges) August 2012 September 2012 December 2012 February 2013
Leukocytes (4.500–11.00 109/L) 20.120–24.590 8.660 13.260 10.260–19.690
Neutrophils (1.900–8.000 109/L) 17.340 5.340 7.420 6.980–17.150
Hemoglobin (14.0–18.0 g/dL) 21–18.3 9.9–10.9 18.6 20.0–24.4
Hematocrit (40%–50%) 65–55 30.3–33.1 55% 58.1–66.8
Platelets (150–400 1000/mmc) 149–232 348–383 245 198
C-reactive protein (0.0–0.5mg/L) 1.8 0.28 1.67 1.82
Procalcitonin (0.0–0.5mcg/L) <0.5 — — —
ESR (1–24mm/h) 5 — 24 —
Glucose (74–106mg/dL) 95 76 118 177
Creatinine (0.50–1.30mg/dL) 2.48–1.72 0.67 1.20 1.21–2.67
Urea (18–50 g/dL) 120–77 38 39 33–72
Uric acid (3.5–7.2mg/dL) 8.4–9.9 — — —
Sodium (135–145mmol/L) 132 139 143 134
Potassium (3.5–5.1mmol/L) 4.9–5.2 3.5 4.1 4.9
Calcium (2.15–2.50mmol/L) 2.06 2.16 — 2.16
Magnesium (0.66–1.07mmol/L) 0.93 — — —
AST (10–35U/L) 283–186–29 128–22 17 9
ALT (10–55U/L) 179–301–7 269–37 7 —
GGT (1–55U/L) 198 84–35 18 —
Albumin (35–52 g/L) 24.4–17.0 36–41.9 37.0–29.0 —
CPK (10–171U/L) 73–278–3.000–10.000 44 140 —
Mioglobin (15–91 ng/mL) — — — 737
Aldolase (0.0–7.9U/L) 16.5 — — —
Troponin T (0–13 ng/L) 117–159 — — —
Troponin I (0.00–0.06 ng/mL) — — — 11.03
PT, INR 1.16 1.04 1.01 1.19
aPTT, s 34 0.95 0.83 1.14
AT III (80%–120%) 58–63 — 82 68
Fibrinogen (150–400mg/dL) 360 — 342 400
Haptoglobin (0.36–1.95 g/L) 2.08 — — —
LDH (100–190U/L) 563–507 221 179 —
Complement C3 (0.79–1.52 g/L) 0.57–0.52 — — —
Complement C4 (0.16–0.40 g/L) 0.17–0.13 — — —
C1-inhibitor (0.18–0.32 g/L) 0.28 — — —
Rheumatoid factor Negative — — —
Monoclonal IgG/l, g/L 1.35 — — —
IgG (7.0–15.6 g/L) 4.53–3.57 — — —
IgA (0.8–4.50 g/L) 1.47–0–98 — — —
IgM (0.46–3.00 g/L) 0.28–0–34 — — —
Triptase (1.0–11.4mg/L) 6.87 — — —
b2 Microglobulin 6.6mg/L — — —
Antinuclear antibodies Negative — — —
ENA (anti-dsDNA, anti-Sm, anti-U1RNP,
anti-SSA/SSB, anti-Scl70, anti-Jo1 antigens)
Negative — — —
ANCA Negative — — —
JAK-2 - V617F gene mutation Absent — — —
PSA (0.1–4.0 ng/mL) 10.6 1.83 — —
Urine analysis
Urine proteins (0–0.15 g/24 h) 0.25–0.63 0.15–0.15 1.12 —
Blood culture Negative — — —
Urine culture Negative — — —
ANA¼ antinuclear antibodies, ANCA¼ antineutrophil cytoplasm antibodies, ALT¼ alanine transaminase, aPTT¼ activated partial thrombo-
plastin time, AST¼ aspartate aminotransferase, AT¼ antithrombin, CPK¼ creatine phosphokinase, dsDNA¼ double-stranded DNA,
ENA¼ extractable nuclear antibodies, ESR¼ erythrocyte sedimentation rate, GGT¼g-glutamyl transferase, IgA¼ immunoglobulins of class A,
IgG¼ immunoglobulins of class G, IgM¼ immunoglobulins of class M, INR¼ international normalized ratio, JAK2¼ Janus kinase 2, Jo1¼ histidyl-
transfer ribonucleic acid synthetase antigen, LDH¼ lactate dehydrogenase, PSA¼ prostate-specific antigen, PT¼ prothrombin time, Scl70¼ scler-
oderma 70 kD antigen, Sm¼Smith antigen, SSA¼Sjo¨gren’s syndrome related antigen A, SSB¼Sjo¨gren’s syndrome related antigen B,
U1RNP¼U1 ribonucleoprotein complex.
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FIGURE 1. (A and B) Early phase of acute myocardial infarction.
Zancanaro et aldevelopment of the anasarcatic state and not before. Acute
rhabdomyolysis was therefore a consequence of the plasma
leakage and development of acute compartment syndrome. This
is a serious complication of SCLS reported during the extra-
vasation and recovery phase. It is caused by the escape of fluids
into the muscular compartment of the extremities that increases
tissue pressures inside this compartment, and fluid resuscitation
may exacerbate this complication. Rhabdomyolysis following
the compartment syndrome contributes to the onset of acute
kidney insufficiency, as ultimately occurred in our patient.14–16
Investigation of the hypotensive episode led to the exclusion of
adrenal mineralocorticoid and corticosteroid insufficiencies. A
normal serum tryptase excluded a systemic mastocytosis or
anaphylaxis, whereas a normal C1-esterase level excluded
angioedema.
The histological findings, exceptionally reported in these
patients, are not specific and reflect the leakage of fluids into
different compartments with an anasarcatic state. In this patient,
we found a significant involvement of the myocardium charac-
terized by a remarkable interstitial edema with evidence of
Images show diffuse and prominent contraction bands of myo-
cardial fibers and polymorphonucleocytes in the interstitium
(hematoxylin and eosin stain).acute myocardial ischemia in its early stage (Figure 1A and B).
This represents a rare complication in SCLS and may be
associated with major arrhythmias that may be the final cause
4 | www.md-journal.comof death in our patient. As expected, we did not have morpho-
logical evidences of coronary vessel lesions and secondary
ischemic abnormalities.
Because the etiology of SCLS is unknown, prophylactic
treatment remains no evidence-based and mainly empiric.
Many different treatments have been attempted, such as b2-
agonist, Gingko biloba extract, IVIG, and leukotriene receptor
antagonists.3 Recent research demonstrates IVIG to be a prom-
ising alternative treatment strategy for SCLS, functioning
possibly through their anticytokine properties and immunomo-
dulating effects.17,18 Xie et al18 reported that IVIG prophylaxis
(1–2 g/kg/mo) performed in 18 patients induced a dramatic
reduction in the number of episodes of hypovolemic shock and
edema in patients with classic acute SCLS. The median yearly
attack frequency was 2.6 per patient prior to IVIG therapy and
nil per patient following initiation of IVIG prophylaxis, with
minimal side effects.
CONCLUSIONS
Studies on SCLS are limited for the rarity of the disease
and its unpredictable course. Even if the diagnosis of SCLS is
achieved, its treatment is largely empirical, and optimal man-
agement of severe attacks in intensive care units is still lacking
and should be a future goal. IVIG may be considered a frontline
therapy for subjects with a clear-cut diagnosis of SCLS and
recurrent attacks.
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CoMain Take Home Lessons of This Case Report
SCLS is characterized by:(1) recurrent episodes of distributive and hypovolemic shock,(2) generalized edema due to fluid extravasation, that may lead
to compartment syndrome,(3) severe hemoconcentration with high hematocrit,
(4) hypoalbuminemia, and(5) unresponsiveness to fluid administration.
Acute crisis is life-threatening, but periods between attacks
are usually asymptomatic.
A monoclonal IgG gammopathy is frequent in adult
patients.
The treatment of acute crisis is largely empirical, and
optimal management of severe attacks is still lacking.
Prophylactic therapy with high doses of IVIG seems help-
ful in the prevention of acute crisis.
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